Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
22.07. | Magnasense AB: Magnasense enters into a conditional agreement regarding a reverse takeover of Subgen AI Limited | 85 | GlobeNewswire (Europe) | NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, HONG KONG, NEW ZEALAND, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND... ► Artikel lesen | |
14.07. | Magnasense AB: The Letter of Intent with Subgen AI Limited regarding reverse takeover has been extended | 133 | GlobeNewswire (Europe) | Magnasense AB ("Magnasense" or the "Company") announces a further extension of the Letter of Intent regarding a potential reverse takeover (the "Transaction") with Subgen AI Limited ("Subgen"), a UK-based... ► Artikel lesen | |
14.07. | Magnasense AB: Magnasense AB files appeal against decision by Swedish Financial Supervisory Authority | 70 | GlobeNewswire (Europe) | Magnasense AB has today filed an appeal with the Administrative Court in Stockholm against the decision by the Swedish Financial Supervisory Authority (Finansinspektionen) dated 25 June 2025 regarding... ► Artikel lesen | |
07.07. | Magnasense AB: Vasiliki Fragkou Resigns from her position as Chief Operating Officer of Magnasense AB and as a director of AegirBio UK Ltd. | 81 | GlobeNewswire (Europe) | Magnasense/AegirBio UK Ltd. announces that Vasiliki Fragkou has officially stepped down from her position.
We would like to sincerely thank Vasiliki for her dedication and contributions during her time... ► Artikel lesen | |
29.06. | Magnasense AB: The Letter of Intent with Subgen AI Limited regarding reverse takeover has been extended | 115 | GlobeNewswire (Europe) | Magnasense AB ("Magnasense" or the "Company") announces an extension of the Letter of Intent regarding a potential reverse takeover (the "Transaction") with Subgen AI Limited ("Subgen"), a UK-based... ► Artikel lesen | |
25.06. | Magnasense AB: Magnasense AB receives decision on penalty fee from the Swedish Financial Supervisory Authority | 176 | GlobeNewswire (Europe) | The Swedish Financial Supervisory Authority ("SFSA") has decided to impose a fine of SEK 12 million on Magnasense AB ("Magnasense" or the "Company") for violations of MAR.
On 14 April 2023, the SFSA... ► Artikel lesen | |
10.06. | Magnasense AB receives observation status | 151 | GlobeNewswire | Today, June 10, 2025, Magnasense AB (the "Company") issued a press release with information that the Company has signed a letter of intent regarding a reverse takeover of SUBGEN AI LIMITED.
According... ► Artikel lesen | |
10.06. | Magnasense AB: Magnasense enters into Letter of Intent with Subgen AI Limited regarding a reverse takeover | 161 | GlobeNewswire (Europe) | Magnasense AB ("Magnasense" or the "Company") announces today that the Company has entered into a non-binding letter of intent ("Letter of Intent") with SUBGEN AI LIMITED, registration number 15374966... ► Artikel lesen | |
MAGNASENSE Aktie jetzt für 0€ handeln | |||||
05.05. | Magnasense AB: Interview with Magnasense: Key Insights from the RADx Initiative | 204 | GlobeNewswire (Europe) | Q: Could you tell us about the primary goal of the RADx initiative and the role Magnasense played in it? A: The RADx initiative aimed to develop a Multiplex Diagnostic Platform that could detect COVID-19... ► Artikel lesen | |
28.04. | Magnasense AB: Magnasense AB Targets Gum Disease Market with Groundbreaking Diagnostic Technology - Capital Raise Underway to Accelerate Entry in High-Value Underserved Market | 125 | GlobeNewswire (Europe) | Magnasense AB, an innovator in smart diagnostics, is preparing to enter one of the largest yet underserved healthcare markets: periodontal (gum) disease. Magnasense is currently advancing its digital... ► Artikel lesen | |
24.04. | Magnasense AB: Overview of the Rights Issue in Magnasense AB | 146 | GlobeNewswire (Europe) | NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, HONG KONG, NEW ZEALAND, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND... ► Artikel lesen | |
22.04. | Magnasense AB: Magnasense AB Develops Innovative Saliva Test for Gum Disease Detection | 150 | GlobeNewswire (Europe) | Rights Issue to Support Development of Groundbreaking Diagnostic Tool
Magnasense AB, a company specializing in rapid diagnostics, is in the process of developing a non-invasive saliva-based test designed... ► Artikel lesen | |
22.04. | Magnasense AB: Magnasense AB publishes information memorandum due to upcoming rights issue of units | 169 | GlobeNewswire (Europe) | NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, HONG KONG, NEW ZEALAND, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND... ► Artikel lesen | |
17.04. | XFRA CAPITAL ADJUSTMENT INFORMATION - 17.04.2025 | 523 | Xetra Newsboard | Das Instrument 52Q SE0014401121 MAGNASENSE AB EQUITY wird ex Kapitalmassnahme gehandelt am 17.04.2025 The instrument 52Q SE0014401121 MAGNASENSE AB EQUITY is traded ex capital adjustment on 17.04.2025Das... ► Artikel lesen | |
10.04. | Magnasense AB: Magnasense resolves on the previously announced rights issue of units of a minimum of approx. MSEK 15 and a maximum of approx. MSEK 26.7 to develop saliva-based diagnostics as an alternative to blood testing | 98 | GlobeNewswire (Europe) | NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, HONG KONG, NEW ZEALAND, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND... ► Artikel lesen | |
05.03. | Magnasense AB: Magnasense Interim Report October - December 2024 | 160 | GlobeNewswire (Europe) | "We are expanding our product capabilities as well as advancing solutions that are directly aligned with our professional market focus in oral health." Marco Witteveen, CEO of Magnasense AB
October... ► Artikel lesen | |
28.02. | XFRA CAPITAL ADJUSTMENT INFORMATION - 28.02.2025 | 253 | Xetra Newsboard | Das Instrument 7OK MHY641771016 OKEANIS ECO TANK. DL-,001 EQUITY wird cum Kapitalmassnahme gehandelt am 28.02.2025 und ex Kapitalmassnahme am 03.03.2025 The instrument 7OK MHY641771016 OKEANIS ECO TANK.... ► Artikel lesen | |
15.11.24 | Magnasense AB: Magnasense Interim Report July - September 2024 | 289 | GlobeNewswire (Europe) | "We are expanding our product capabilities as well as advancing solutions that are directly aligned with our professional market focus in oral health." Marco Witteveen, CEO of Magnasense AB
July - October... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FRESENIUS | 43,740 | +3,45 % | Fresenius vor Zahlen: Darauf kommt es an | Am morgigen Mittwoch (06. August) wird der Gesundheitskonzern Fresenius die Zahlen für das abgelaufene zweite Quartal 2025 vorlegen. DER AKTIONÄR zeigt auf, was die Analysten vom Bad Homburger Unternehmen... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 46,430 | +0,56 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 41,150 | +0,56 % | FMC-CFO Martin Fischer - "Wir werden zuverlässig liefern" | Nach dem Kapitalmarkttag Mitte Juni waren bei Analysten Zweifel aufgekommen, ob Fresenius Medical Care die bis 2030 versprochene Margenverbesserung tatsächlich erreichen kann. Im exklusiven Interview... ► Artikel lesen | |
CARL ZEISS MEDITEC | 43,040 | -0,65 % | HAUCK AUFHÄUSER INVESTMENT BANKING stuft CARL ZEISS MEDITEC AG auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Hauck Aufhäuser Investment Banking hat das Kursziel für Carl Zeiss Meditec von 86,50 auf 70,00 Euro gesenkt und die Einstufung auf "Buy" belassen. Alexander Galitsa begründete... ► Artikel lesen | |
PROGYNY | 22,850 | -0,91 % | Progyny, Inc. Announces Second Quarter 2025 Results | Reports Record Revenue of $332.9 Million, Reflecting 9.5% GrowthGenerates $55.5 Million in Quarterly Operating Cash Flow and Record $105.3 Million over the First Half of 2025 Raises Full Year Guidance... ► Artikel lesen | |
ECKERT & ZIEGLER | 58,80 | -9,54 % | EQS-News: Eckert & Ziegler SE: Umsetzung des Aktiensplits durch Ausgabe von Gratisaktien erfolgt am 15. August 2025 | EQS-News: Eckert & Ziegler SE
/ Schlagwort(e): Kapitalmaßnahme
Eckert & Ziegler: Umsetzung des Aktiensplits durch Ausgabe von Gratisaktien erfolgt am 15. August 2025
05.08.2025... ► Artikel lesen | |
GERRESHEIMER | 45,780 | +0,79 % | EQS-Adhoc: Gerresheimer AG: Gerresheimer separiert Moulded Glass und beabsichtigt anschließend einen Verkaufsprozess zu initiieren | EQS-Ad-hoc: Gerresheimer AG / Schlagwort(e): Strategische Unternehmensentscheidung/Verkauf
Gerresheimer AG separiert Moulded Glass und beabsichtigt anschließend einen Verkaufsprozess... ► Artikel lesen | |
HEARTFLOW | 29,880 | 0,00 % | Heartflow, Inc. Announces Pricing of Upsized Initial Public Offering | MOUNTAIN VIEW, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), a leader in AI technology for coronary artery disease (CAD), today announced the pricing of its... ► Artikel lesen | |
UNITEDHEALTH | 215,45 | -0,05 % | UnitedHealth: Nächster Rückschlag | Viele Jahre galt die Aktie von UnitedHealth als Dauerläufer. Als Fels in der Brandung. Doch in den zurückliegenden Monaten sorgten zahlreiche negative Neuigkeiten dafür, dass der Dow-Jones-Wert binnen... ► Artikel lesen | |
PROCEPT BIOROBOTICS | 38,470 | -2,83 % | PROCEPT BioRobotics Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance | SAN JOSE, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
MEDIROM HEALTHCARE TECHNOLOGIES | 2,710 | +125,83 % | Medirom Healthcare Surges Over 79% In Pre-Market After Deal To Deploy Sam Altman-Backed World ID | ||
ALIGNMENT HEALTHCARE | 14,510 | +4,69 % | Alignment Healthcare Reports Second Quarter 2025 Results; Raises Full-Year Outlook Across All Key Metrics | Reports total revenue of $1.0 billion in Q2 and 223,700 health plan members as of June 30, up 49.0% and 27.8% year-over-year respectively Surpasses high-end of Q2 guidance across all key metrics:... ► Artikel lesen | |
OPTIMIZERX | 17,340 | +35,05 % | OptimizeRx Corporation: OptimizeRx Reports Second Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance | Q2 revenue of $29.2 million, increased 55% year-over-yearQ2 gross profit increased 59% year-over-year to $18.6 millionPaid down $4.5 million of principal on outstanding term loan during Q2Increased... ► Artikel lesen | |
PRIVIA HEALTH GROUP | 20,585 | +5,51 % | Privia Health Group, Inc.: Privia Health Reports Second Quarter 2025 Financial Results | Very Strong First Half Performance Across All Key Operating and Financial MetricsImplemented Providers +13.8% and Practice Collections +18.5% compared to 2Q'24Guidance Raised to Above High End of... ► Artikel lesen | |
LIFESTANCE HEALTH GROUP | 4,370 | +13,21 % | LifeStance Health Group, Inc.: LifeStance Reports Second Quarter 2025 Results | SCOTTSDALE, Ariz., Aug. 07, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen |